Brief: Xspray Pharma To Receive About SEK 113 Million From Rights, Over-Allotment Issues
23/04/2026 07:19
April 23 (Reuters) - Xspray Pharma publ AB XSPRAY.ST: TO RECEIVE ABOUT SEK 113 MILLION FROM RIGHTS AND OVER-ALLOTMENT ISSUES TO ISSUE 4,174,234 SHARES IN FULLY SUBSCRIBED RIGHTS ISSUE TO RECEIVE ABOUT SEK 83 MILLION FROM RIGHTS ISSUE, BEFORE DEDUCTION COSTS Source text: ID:nMFN1zMRWZ Further company coverage: XSPRAY.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Xspray Pharma publ AB
See all newsBrief: Xspray Pharma Gets CRL From FDA
Sweden's Xspray Q1 loss narrows, upbeat on Dasynoc prospects
Brief: Xspray Pharma Q1 Pretax Loss SEK 35.4 Mln
Brief: Xspray Pharma To Receive About SEK 113 Million From Rights, Over-Allotment Issues
Brief: FDA Accepts Trade Name Nilopki For Xspray's Drug Candidate XS003